(Q40029578)

16 September 2017

title

Sustained moderate visual loss as a predictive end point for visual loss in non-proliferative diabetic retinopathy (English)

1 reference

16 September 2017

A Girach

1

1 reference

16 September 2017

L P Aiello

2

1 reference

16 September 2017

R C Milton

3

1 reference

16 September 2017

M D Davis

4

1 reference

16 September 2017

R P Danis

5

1 reference

16 September 2017

X Zhi

6

1 reference

16 September 2017

M J Sheetz

7

1 reference

16 September 2017

L Vignati

8

1 reference

16 September 2017

PKC-DRS2 Study Group

9

1 reference

16 September 2017

publication date

7 November 2008

1 reference

16 September 2017

1 reference

16 September 2017

volume

23

1 reference

16 September 2017

issue

1

1 reference

16 September 2017

page(s)

209-214

1 reference

The prevalence of diabetic retinopathy among adults in the United States

16 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2008.324

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2008.324

Pharmacological approach to diabetic retinopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2008.324

Changing times for the management of diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2008.324

Effect of ruboxistaurin on visual loss in patients with diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2008.324

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2008.324

7 January 2021

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2008.324

7 January 2021

Preliminary report on effects of photocoagulation therapy. The Diabetic Retinopathy Study Research Group

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2008.324

7 January 2021

Photocoagulation for Diabetic Macular Edema

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2008.324

7 January 2021

Identifiers

DOI

10.1038/EYE.2008.324

1 reference

Dimensions Publication ID

16 September 2017

1053534013

0 references

1 reference